NitroMed, Inc and Archemix Corp, a privately-held biopharmaceutical company working to develop aptamer-based therapeutics, announced that they have entered into a definitive merger agreement under which Archemix will merge with NitroMed in an all-stock transaction.
The details can be read here.
No comments:
Post a Comment